ThromBio
Biotechnology Research • 
Australia • 1-10 Employees
Company overview
| Headquarters | Australia |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Drug Discovery, Drug Development, Medical Research, Clinical Trials, Biomedicine, Biotechnology Research, Stroke Research, Thrombolysis, Australian Drug Development, Tbo-309, Tbo-309 Drug, Thrombio, Thrombio Holdings, Anti-Thrombotic Drug, Breakthrough Scientific Studies, Breakthroughs In Medicine, Experimental Biomedicine, Medical Treatment Development, Reasearch In Stroke, Stroke Drug |
| Founded | 2020 |
| Employees | 1-10 |
Key Contact at ThromBio
Shaun Jackson
Founder And Director
ThromBio Email Formats
ThromBio uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@thrombio.com.au), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@thrombio.com.au | 100% |
About ThromBio
ThromBio is a drug discovery company whose mission is to advance the global standard of care for the treatment of stroke using novel anti-thrombotic drugs with unprecedented safety and efficacy. Leadership: ThromBio’s programme is driven by international leaders in drug discovery & development, experimental biomedicine, global clinical trials capability and commercialisation. Our Lead Candidate: TBO-309 TBO-309 represents an Australian drug development success story, that has resulted in a novel antiplatelet compound with truly remarkable properties. Lead Indications: Acute Ischaemic stroke remains the second largest cause of death and disability globally, with 85% of all strokes caused by blood clots that block blood flow to the brain. TBO-309 is currently being trialled in patients in Phase II clinical trials, as an adjunct to thrombolysis (STARS). Publications: ThromBio’s technology is built around state-of-the-art science and technology, published by internationally recognised leaders in the field of drug discovery & and experimental biomedicine. Media: ThromBio’s technology has received global attention for its breakthrough scientific studies. Contact us on social@thrombio.com.au or for more information look at our website.
ThromBio revenue & valuation
| Annual revenue | $769,995 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,500,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
ThromBio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
ThromBio has never raised funding before.
ThromBio Tech Stack
Discover the technologies and tools that power ThromBio's digital infrastructure, from frameworks to analytics platforms.
PaaS
JavaScript frameworks
Security
JavaScript frameworks
Miscellaneous
PaaS
Font scripts
United States
Canada
Spain
United Arab Emirates
BrazilFrequently asked questions
4.8
40,000 users
